Q2 STOCKS TO BUY

REGN Rises on Quarterly Win, Potential COVID-19 Treatment Approval

The equity is up over 81% year-over-year

Digital Content Manager
Nov 5, 2020 at 3:24 PM
facebook X logo linkedin


The shares of Regeneron Pharmaceuticals Inc (NASDAQ: REGN) are up 0.3% at $588.86 at last check, after the company reported third-quarter earnings of $8.36 per share -- significantly higher than Wall Street's estimates of $7.14 per share -- as well as a revenue beat. The pharmaceutical concern attributed the strong results to a 9% jump in sales of eye drug Eylea. In addition, U.S. health regulators are currently analyzing the company's experimental COVID-19 antibody cocktail, which could soon be approved for emergency use.

Digging deeper, REGN has been cooling off from an July 20 all-time-high of $664.64 over the last couple of months. And while shares are struggling with overhead pressure at the $600 level, today's pop has the security consolidating above the 60-day moving average, which had emerged as a ceiling after a lengthy period of support. Year-over-year, the stock is up 81.8%.

REGN 60 Day

Analysts are mostly split toward the security, with 11 of the 20 in question sporting a "strong buy" rating, and the remaining nine sporting a tepid "hold."  Meanwhile, the 12-month consensus target price of $673.08 is a whopping 14.1% premium to the stock's current perch. 

Shorts are building their positions, too. Short interest is up 45.6% in the the last two reporting periods, and the 2.33 million shares sold short account for a significant 2.3% of the stock's available float. At the stock's average pace of trading, it would take roughly three days to buy back these bearish bets.

The options pits are leaning pessimistic, with puts popular. This is per the stock's 10-day put/call volume ratio of 2.40 at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), which stands higher than all readings from the past year. This indicates puts are being picked up at a faster-than-usual pace. 

 
 

“Buy This Stock Now!” - Expert Who Called 11x On TSLA

He called a rare 11x on Tesla…

But now, thanks to Elon & Trump’s new alliance…

He says there’s a new opportunity that could be 1,000x BIGGER than Tesla – and it could completely revolutionize a $23 Trillion market.

It’s trading for less than $5 per share right now…

But it won’t be under the radar for long.

Discover The 1,000x Bigger Elon Opportunity Here

GRAND SLAM COUNTDOWN

 
 

Featured Articles from Trusted Partners:

👀Learn How Dividends Create Passive Income for Life
Receive $200 Off Motley Fool Epic. The Motley Fool Epic $299 discounted offer is based on $499/year list price. Introductory promotion for new members only. Take control of your money and your portfolio with Motley Fool Epic.

💵New Income System Could Pay You $4,243 Monthly
You could collect an average of $4,243 per month starting as early as next week with a new payout system for income investors. New registrations are being accepted for investors who want to be in a position to start with their first payout next week.

🚀Easy 92% Crypto Dividends (No Coins Required)
COIN stock doesn't pay a dividend... But there's actually a new way to collect a massive dividend that's indirectly based on the stock and offers a terrific monthly income (currently yielding nearly 92% on a forward basis).

🤝Free Advisor Match with Wiseradvisor.com
Don't leave your retirement to chance! Get matched with a trusted financial expert for FREE and make the most of your tax refund. Get started now.

⚠️Dennis Quaid's #1 Warning for Americans
Here's the thing: life doesn't come with guarantees. The economy shifts, markets stumble, and years of hard work could slip through your fingers like sand. But it doesn't have to be that way for you. So request a free copy of this Gold & Silver Guide that will arrive right to your doorstep when you act now.

 

 
 

Follow us on X, Follow us on Twitter